Palani Sharmiladevi

Palani Sharmiladevi

Auto-generated profile, based on publicly available information

Palani Sharmiladevi

Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research & Education (CARE), Kelambakkam, Chennai, 603 103, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2019 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
PSPalani Sharmiladevi
Palani Sharmiladevi
NANajim Akhtar
Najim Akhtar
VHViswanathan Haribabu
Viswanathan Haribabu
KGKoyeli Girigoswami
Koyeli Girigoswami
SUROJIT CHATTOPADHYAYSUROJIT CHATTOPADHYAY
SUROJIT CHATTOPADHYAY
Agnishwar GirigoswamiAgnishwar Girigoswami
Agnishwar Girigoswami

7 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Agnishwar GirigoswamiAgnishwar Girigoswami
Agnishwar Girigoswami
WYWafic Yassine
Wafic Yassine
PSPalani Sharmiladevi
Palani Sharmiladevi
VHViswanathan Haribabu
Viswanathan Haribabu
KGKoyeli Girigoswami
Koyeli Girigoswami
The present study shows the thorough investigations on optical properties and hydrodynamic diameters of glutathione (GSH) stabilized nanosilver clusters (AgNC) at different stages of synthesis and engineering for the optimized absolute quantum yield to generate fluorescent images of Dalton Lymphoma Ascites (DLA) tumour bearing mice. The initial increment of quantum yield was wavelength dependent and finally it became 0.509 which was due to the camouflaging or entrapment of AgNC in macrophages membranes. The potentiality of macrophages membrane camouflaged silver nanoclusters (AgM) was reflected in the cell viability assay and confocal based live dead cell assay where the AgM has better cell killing effect compared to AgNC with reduced dosage and in vivo mice imaging generated the clear visualization at the tumour sites. Therefore, from the present study, it can be considered that the camouflaged nanosilver can be used for targeted theranostic applications.

1 February 2019 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
VHViswanathan Haribabu
Viswanathan Haribabu
PSPalani Sharmiladevi
Palani Sharmiladevi
NANajim Akhtar
Najim Akhtar
AFAbubacker Sulaiman Farook
Abubacker Sulaiman Farook
KGKoyeli Girigoswami
Koyeli Girigoswami
Agnishwar GirigoswamiAgnishwar Girigoswami
Agnishwar Girigoswami
Objective: The label free ultrasmall fluorescent ferrite clusters have been engineered in a controlled fashion which was stabilized by serum protein and functionalized by folic acid for the application of targeted multimodal optical and Magnetic Resonance (MR) cancer imaging. Methods: The ultra-small manganese ferrite nanoclusters (PMNCs) with a diameter of 4 nm have a commendable effect on the longitudinal (T1) and transverse (T2) relaxation in MR imaging that was evident from the phantom and animal MRI. Results: The calculated longitudinal molar relaxivity of nanoclusters was found to be 6.9 ± 0.10 mM-1 S-1 which was exactly 2.22 times better than the conventional Gd-DOTA and their 4.01 ratio of the transverse (r2) and longitudinal (r1) relaxivities made them a potential candidate for both T1 and T2 contrast agents in MRI. In addition, the fluorescence-based small animal imaging showed folic acid driven accumulated fluorescent signal at the tumour site to conclude the capacity of PMNCs for targeted fluorescence imaging of cancer diagnosis. Conclusion: The cytotoxicity assay and histopathology studies were the evidence for their safe biodistribution in animal systems. Furthermore, the protein encapsulated clusters have the ability to deliver the anticancer drug Methotrexate (MTX) to the cancer tissues with a sustained manner. Therefore, one can conclude the remarkable efficacy of architect nanoclusters for theragnosis.

11 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PSPalani Sharmiladevi
Palani Sharmiladevi
VHViswanathan Haribabu
Viswanathan Haribabu
KGKoyeli Girigoswami
Koyeli Girigoswami
AFAbubacker Sulaiman Farook
Abubacker Sulaiman Farook
Agnishwar GirigoswamiAgnishwar Girigoswami
Agnishwar Girigoswami
In the present work, an attempt was made to engineer a mesoporous silica coated magnetic nanoparticles (MNF@mSiO2) for twin mode contrast in magnetic resonance imaging (MRI) with reduced toxicity. Superparamagnetic manganese ferrite nanoparticles were synthesized with variable mesoporous silica shell thickness to control the water molecules interacting with metal oxide core. 178 nm was the optimum hydrodynamic diameter of mesoporous ferrite core-shell nanoparticles that showed maximum longitudinal relaxation time (T1) and transverse relaxation time (T2) in MRI due to the storage of water molecules in mesoporous silica coating. Besides the major role of mesoporous silica in controlling relaxivity, mesoporous silica shell also reduces the toxicity and enhances the bioavailability of superparamagnetic manganese ferrite nanoparticles. The in vitro toxicity assessment using HepG2 liver carcinoma cells shows that the mesoporous silica coating over ferrite nanoparticles could exert less toxicity compared to the uncoated particle.

1 November 2022 in Current Nanoscience
Verified
Journal Article
Closed access
PDF file
Agnishwar GirigoswamiAgnishwar Girigoswami
Agnishwar Girigoswami
PPPragya Pallavi
Pragya Pallavi
PSPalani Sharmiladevi
Palani Sharmiladevi
VHViswanathan Haribabu
Viswanathan Haribabu
KGKoyeli Girigoswami
Koyeli Girigoswami
: Conventional treatment modalities for tumors face a variety of pitfalls, including nonspecific interactions leading to multiple adverse effects. These adverse effects are being overcome through innovations that are highly intense and selective delivery of therapeutic agents. More recently, Photodynamic therapy (PDT) has gained its value over conventional chemo- and radiotherapies due to the use of photosensitizers (PS) with an illuminating light source. Photosensitizers have crossed three generations with Photofrin being the first clinically approved PS for PDT. Even though these PS have proved to have cytotoxic effects against tumor cells, they suffer the selective distribution and concentration into the tumor sites that are deeply localized. To overcome these disadvantages, nanoformulations are currently being employed due to their unmatched physicochemical and surface properties. These nanoformulations include the encapsulation of PS acting as a nanocarrier for the PS or the functionalization of PS onto the surface of nanoparticles. The design of such nanoformulations involved in PDT is critical and valuable to consider. Along with PDT, several multifunctional approaches are being uplifted in the current trend where combined therapy and diagnosis are of great importance. Furthermore, targeted, selective, and specific delivery of the PS-loaded nanoformulations with receptor- mediated endocytosis is of interest to achieve better internalization into the tumor site. ROS generation with the interaction of PS augments cell death mechanisms exhibited due to PDT, leading to the immunogenic response that further results in an adaptive immune memory that prevents recurrence of tumor metastasis. Therefore, this review concentrates on the mechanisms of PDT, examples of nanocarriers and nanoparticles that are employed in PDT, combined therapies, and theranostics with PDT. Moreover, molecular mechanisms of nano-based PDT agents in killing tumor sites and designing considerations for better PDT outcomes have been discussed.

18 June 2025 in ADMET and DMPK
Verified
Journal Article
Open access
PDF file
ATAnbazhagan Thirumalai
Anbazhagan Thirumalai
PSPalani Sharmiladevi
Palani Sharmiladevi
KGKoyeli Girigoswami
Koyeli Girigoswami
APAlex Daniel Prabhu Arul Pitchai
Alex Daniel Prabhu Arul Pitchai
Agnishwar GirigoswamiAgnishwar Girigoswami
Agnishwar Girigoswami
Background and purpose: Multifunctional hybrid nanoparticles garner heightened interest for prospective biomedical applications, including medical imaging and medication administration, owing to their synergistic benefits of constituent components. Therefore, we demonstrated an optimized protocol for synthesizing magnetofluorescent nanohybrids comprising fluorescent carbon dots with magnetic nanoparticles. Experi­mental approach: Carbon dot-coated iron oxide nanoparticles (CDs@Fe2O3) were synthesized with varying citric acid concentrations by a one-pot hydrothermal synthesis method for the development of a low-cost and biocompatible contrast agent (CA) for enhanced multimodal imaging (fluorescent and T1 and T2 weighted magnetic resonance imaging (MRI)) to replace the conventional CAs. Key results: The physico­chemical characterization of the synthesized CDs@Fe2O3 revealed that 3 g of citric acid used for the synthesis of nanoparticles, keeping Fe(II) and Fe(III) ratio 1:2 provides higher stability of -78 mV zeta potential, saturation magnetization of 24 emu/g, with a hydrodynamic diameter of 68 nm. Carbon coating affects surface spins on Fe2O3, resulting in fewer surface-based relaxation centres, making T1 relaxation relatively more prominent. Furthermore, the surface-engineered iron oxide NPs are efficient in producing both T1 and T2 weighted MRI as well as fluorescence-based imaging. The molar relaxivity and molar radiant efficiency derived from phantom studies demonstrate their effectiveness in multimodal medical imaging. The cyto­toxicity assay, haemolysis assay, haematology, and histopathology studies show that the optimized CDs@Fe2O3 are biocompatible, haemocompatible, and negligibly toxic. Conclusion: We can conclude the significant potency of CDs@Fe2O3 for multimodal diagnosis.